---  
layout: startup_page  
title: "Alveron Pharma"  
id: "alveron.com"  
permalink: "/alveronpharmaalveron.com12062024/"  
website: "https://www.alveron.com/"  
funding_round: "Seed+"  
funding_amount: "€5M"  
investors: "Broadview Ventures, Sanquin, Thuja Capital, Waterman Ventures, Oost NL"  
about: "Alveron Pharma is developing OKL-1111, a synthetic anticoagulant and platelet inhibitor reversal agent, to improve outcomes for intracranial hemorrhage (ICH) patients. Current ICH treatments have lengthy administration times, while OKL-1111 offers a faster, more effective solution by binding to a downstream clotting factor and reversing the effects of clopidogrel. This accelerates treatment and improves patient outcomes."  
markets: "Biopharmaceuticals, Healthtech, Drug Discovery, Drug Delivery, Pharmaceuticals, Life Sciences"  
hq: "Oss, North Brabant, Netherlands"  
founded_year: "2019"  
linkedin: "https://www.linkedin.com/company/alveron-pharma"  
twitter: ""  
instagram: ""  
facebook: ""  
crunchbase: "https://www.crunchbase.com/organization/alveron-pharma?utm_source=linkedin&utm_medium=referral&utm_campaign=linkedin_companies&utm_content=profile_cta_anon&trk=funding_crunchbase"  
pitchbook: "https://pitchbook.com/profiles/company/268415-38"  

date_display: "06-Dec-2024"  
date: "2024-12-06"

# SEO Optimization  
meta_title: "Alveron Pharma - Seed+ Funding (€5M)"  
meta_description: "Alveron Pharma, Alveron Pharma is developing OKL-1111, a synthetic anticoagulant and platelet inhibitor reversal agent, to improve outcomes for intracranial hemorrhag..."  
meta_keywords: "Alveron Pharma, Biopharmaceuticals, Healthtech, Drug Discovery, Drug Delivery, Pharmaceuticals, Life Sciences, Seed+ funding"  
canonical_url: "https://startup.projectstartups.com/alveronpharmaalveron.com12062024/"  
---